Huntington’s disease
Recent articles
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Huntington’s disease gene variants past a certain size poison select cells
The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.
Explore more from The Transmitter
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.